Affecting approximately 262 million people worldwide, asthma is a chronic condition of the lungs that causes airway inflammation. 1. Typical symptoms include: Breathlessness; Whee ...

The primary symptoms of asthma are typically associated with breathing difficulties - here's what you should know ...

New blood-based metabolomics test predicts asthma attacks up to five years ahead, helping identify high-risk patients before ...

asthma, lungs Authors review changes in the diagnosis, workup, and treatment of asthma in the 2022 GINA report. Some patients with asthma who lack evidence of type 2 inflammation are considered to ...

New research reveals hidden inflammation chemicals in asthma that rise with symptom severity and may allow earlier, simpler ...

Asthma is a respiratory condition caused by inflammation and constriction (narrowing) of the airways. It can cause symptoms such as shortness of breath, coughing, or wheezing. Asthma is a long-term ...

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.